Medical Disclaimer: This content is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any health-related decisions. If you are experiencing a medical emergency, call your local emergency services immediately.
What This Page Explains
Older adults (aged 65 and above) represent the most extensively studied population for Urolithin A supplementation. Age-related mitochondrial dysfunction contributes to sarcopenia, reduced mobility, and declining physical performance in this demographic. Two landmark clinical trials — Liu et al. 2022 (JAMA Network Open) and Andreux et al. 2019 (Nature Metabolism) — provide the strongest human evidence for Urolithin A's effects on muscle endurance, mitochondrial biomarkers, and physical function in this age group. Additionally, a 2025 Nature Aging trial explored Urolithin A's effects on age-related immune decline in older adults, adding a new dimension to the evidence base. This page reviews the population-specific findings, study designs, and limitations relevant to adults aged 65+.
Don't Let Another Year of Cellular Decline Pass You By
Every year you wait, your NAD+ drops further, your mitochondria accumulate more damage, and recovery gets harder. Start today.
Detailed Evidence
WHY OLDER ADULTS ARE A KEY POPULATION Mitochondrial function declines progressively with age, contributing to reduced ATP production, increased oxidative stress, and impaired cellular quality control. By age 70, mitochondrial capacity may be reduced by 25–50% compared to young adults. Since Urolithin A activates mitophagy — the recycling of damaged mitochondria — older adults with the greatest mitochondrial burden stand to benefit most from this mechanism. LIU 2022 — JAMA NETWORK OPEN TRIAL (n=66, ages 65–90) This 4-month randomized, double-blind, placebo-controlled trial is the largest and most rigorous study in older adults. Participants received 1000 mg Urolithin A daily or placebo. Key findings: (1) 6-minute walk test distance improved significantly vs placebo, (2) hamstring muscle endurance (contractions to fatigue) increased by ~12%, (3) hand-grip strength showed improvements in the UA group, (4) plasma acylcarnitines decreased (improved mitochondrial fatty acid oxidation), (5) C-reactive protein decreased ~30% vs placebo. ANDREUX 2019 — NATURE METABOLISM SAFETY TRIAL (n=60, ages 65–90) This first-in-human trial tested escalating doses (250 mg, 500 mg, 1000 mg, 2000 mg) for 28 days. While designed primarily for safety, the study found dose-dependent changes in mitophagy biomarkers: decreased plasma acylcarnitines at 500 mg and 1000 mg, and molecular signatures of mitophagy activation in skeletal muscle biopsies. No serious adverse events were reported at any dose. NATURE AGING 2025 — IMMUNE FUNCTION TRIAL A randomized, placebo-controlled trial published in Nature Aging examined Urolithin A's effects on age-related immune decline (immunosenescence) in older adults. The study reported improvements in certain immune cell populations and reductions in inflammatory markers, suggesting potential immunomodulatory benefits. This is a single trial and clinical significance of observed changes remains to be determined. SAFETY PROFILE IN OLDER ADULTS Across all published trials in older adults, Urolithin A has been well-tolerated. Adverse events were mild and occurred at rates comparable to placebo. The most common reports were mild gastrointestinal symptoms. No clinically significant changes in blood chemistry, liver function, or renal function were observed. Frequently Asked Questions: What age range was studied in the clinical trials? — 65–90 years in the Liu 2022 and Andreux 2019 trials. How much Urolithin A was used in older adult trials? — 250–2000 mg/day; 1000 mg showed the most consistent benefits. Were there side effects in older adults? — Mild GI symptoms at rates comparable to placebo; no serious adverse events. Can Urolithin A prevent sarcopenia? — No trial has measured sarcopenia prevention; improvements in muscle endurance are promising but not conclusive. Does Urolithin A help with immune aging? — The 2025 Nature Aging trial suggests potential immunomodulatory benefits — early-stage evidence.
Evidence Hierarchy
Systematic Reviews & Meta-Analyses
Multiple high-quality trials combined
Randomized Controlled Trials (RCTs)
Gold standard for treatment efficacy
Observational Studies
Can show associations, not causation
Case Reports & Expert Opinion
Hypothesis-generating only
Preclinical (Lab/Animal) Studies
Should NOT be extrapolated to humans
From the Lab to Your Cells: 5 Compounds That Actually Reach the Mitochondria
Piperine-enhanced bioavailability ensures these research-backed compounds get where they need to go — your cellular powerhouses.
Study Quality Indicators
Higher Quality Indicators
- Large sample size (hundreds to thousands)
- Randomized and blinded design
- Placebo-controlled comparison
- Published in peer-reviewed journals
- Replicated in multiple studies
- Registered trial protocol before starting
Lower Quality Indicators
- Small sample size (under 100)
- No control group or blinding
- Manufacturer-funded with conflicts
- Only animal/cell studies
- Never replicated
- Published in predatory journals
Important Limitations
- • Supplement research often has methodological limitations
- • Results from one study may not generalize to all people
- • Marketing claims often exceed what research supports
- • Absence of evidence is not evidence of absence
- • Individual response to supplements varies widely
Quick Answers
What evidence exists for Urolithin A in older adults?
Two landmark trials (Liu 2022, Andreux 2019) in adults aged 65–90 plus a 2025 Nature Aging immune function trial. Benefits include improved 6-minute walk distance, muscle endurance (~12%), hand-grip strength, mitochondrial biomarkers, and ~30% CRP reduction.
Does Urolithin A improve walking ability in seniors?
Yes. The Liu 2022 trial (n=66, ages 65–90) showed significant improvement in 6-minute walk test distance vs placebo over 4 months at 1000 mg/day. The 6MWT is a clinically validated measure of functional exercise capacity.
Is Urolithin A safe for elderly people?
Yes. Across published trials in older adults (65–90), UA was well-tolerated. Adverse events were mild and comparable to placebo. No clinically significant changes in blood chemistry, liver function, or renal function were observed.
Can Urolithin A prevent age-related muscle loss?
No trial has measured sarcopenia prevention directly. The Liu 2022 trial showed improvements in muscle endurance and hand-grip strength, which are relevant to sarcopenia, but prevention of age-related muscle loss has not been proven.
What dose of Urolithin A was used in older adult trials?
The Liu 2022 trial used 1000 mg/day. The Andreux 2019 trial tested 250–2000 mg/day. 500–1000 mg showed biomarker benefits; 1000 mg showed the most consistent functional improvements.
Does Urolithin A help with grip strength in seniors?
Yes. Hand-grip strength — a key indicator of functional health in aging and a validated mortality predictor — improved in older adults taking 1000 mg/day for 4 months in the Liu 2022 trial.
What biomarkers improved in older adults taking Urolithin A?
Plasma acylcarnitines (mitochondrial fatty acid oxidation markers) decreased dose-dependently. C-reactive protein decreased ~30%. Skeletal muscle biopsies showed molecular signatures of mitophagy activation (PINK1/Parkin pathway upregulation).
Does Urolithin A improve immune function in aging?
The 2025 Nature Aging RCT reported improvements in certain immune cell populations and reductions in inflammatory markers in older adults. This is early-stage, single-trial evidence of potential immunomodulatory benefits.
How long did the older adult trials last?
The Liu 2022 trial was 4 months. The Andreux 2019 safety trial was 28 days. No trial longer than 4 months has been published. Long-term effects in older adults are unknown.
Were the older adult trials placebo-controlled?
Yes. Both the Liu 2022 (JAMA Network Open) and Andreux 2019 (Nature Metabolism) trials were randomized, double-blind, and placebo-controlled — the gold standard study design.
Did older adults experience GI side effects?
Mild gastrointestinal symptoms were the most commonly reported adverse events, occurring at rates comparable to placebo. No serious GI adverse events were attributed to UA in any older adult trial.
Can Urolithin A help frail elderly individuals?
Unknown. Published trials enrolled generally healthy older adults (65–90). Effects in frail elderly or those with chronic diseases have not been established. No hard clinical endpoints (falls, hospitalization) were measured.
Does Urolithin A affect mitochondria in older adults?
Yes. Andreux 2019 muscle biopsies showed molecular signatures of mitophagy activation at 500–1000 mg. Plasma acylcarnitines decreased dose-dependently, indicating improved mitochondrial fatty acid oxidation.
What was the sample size in older adult Urolithin A trials?
The Liu 2022 trial had 66 participants and the Andreux 2019 trial had 60. These are small by pharmaceutical standards — larger confirmatory trials are needed.
Is there evidence for Urolithin A in reducing inflammation in seniors?
Yes. CRP decreased ~30% vs placebo over 4 months in the Liu 2022 trial. This is a secondary endpoint but reached statistical significance and is relevant to inflammaging in older adults.
Key Research Facts
In a 4-month RCT (n=66, ages 65–90), 1000 mg/day Urolithin A improved 6-minute walk test distance and hamstring muscle endurance by 12–17% vs placebo.
Strong EvidenceLiu et al., JAMA Network Open — doi:10.1001/jamanetworkopen.2021.44279
The first-in-human Urolithin A trial (n=60, ages 65–90) showed dose-dependent mitophagy biomarker changes at 500 mg and 1000 mg doses over 28 days.
Strong EvidenceAndreux et al., Nature Metabolism — doi:10.1038/s42255-019-0073-4
Urolithin A was well-tolerated in older adults at doses up to 2000 mg/day, with adverse events comparable to placebo across published trials.
Strong EvidenceAndreux et al., Nature Metabolism — doi:10.1038/s42255-019-0073-4
Plasma acylcarnitines — biomarkers of mitochondrial fatty acid oxidation — decreased in a dose-dependent manner in older adults taking Urolithin A.
Strong EvidenceAndreux et al., Nature Metabolism — doi:10.1038/s42255-019-0073-4
C-reactive protein (CRP) decreased by approximately 30% in the Urolithin A group vs placebo over 4 months in older adults.
Moderate EvidenceLiu et al., JAMA Network Open — doi:10.1001/jamanetworkopen.2021.44279
Hand-grip strength — a key indicator of functional health in aging — improved in older adults taking 1000 mg/day Urolithin A for 4 months.
Moderate EvidenceLiu et al., JAMA Network Open — doi:10.1001/jamanetworkopen.2021.44279
A 2025 Nature Aging RCT reported improvements in immune cell populations in older adults taking Urolithin A, suggesting immunomodulatory potential.
Emerging EvidenceNature Aging — doi:10.1038/s43587-025-00996-x
Skeletal muscle biopsies from older adults in the Andreux 2019 trial showed molecular signatures of mitophagy activation at 500 mg and 1000 mg doses.
Moderate EvidenceAndreux et al., Nature Metabolism — doi:10.1038/s42255-019-0073-4
Mitochondrial capacity may decline 25–50% by age 70, making older adults the most relevant population for mitophagy-activating interventions.
Strong EvidenceD'Amico et al., Trends in Molecular Medicine — doi:10.1016/j.molmed.2021.04.009
No serious adverse events were attributed to Urolithin A in any published trial enrolling older adults aged 65–90.
Strong EvidenceLiu et al., JAMA Network Open; Andreux et al., Nature Metabolism — doi:10.1001/jamanetworkopen.2021.44279
Citations & External Resources
ClinicalTrials.gov — Search: Urolithin A
FDA GRAS Notice GRN 000833 — Urolithin A
EFSA Novel Food Catalogue — Urolithin A
PubMed — Urolithin A research
Nature Medicine — Ryu et al. 2016 (Landmark Study)
JAMA Network Open — Liu et al. 2022 (Muscle Endurance RCT)
Nature Metabolism — Andreux et al. 2019 (First Human Trial, 65–90 yr)
Nature Aging — Immune Function Trial 2025
NIH NIA — Aging and Mitochondrial Function
This Page Changed How You Think About Energy. Now Change How You Live.
Knowledge without action is just entertainment. Apply what you've learned and give your cells the support science says they need.
Related Reading
Urolithin A & Healthy Aging: Research Context
Urolithin A for Muscle Endurance: What Human Studies Show
Urolithin A in Middle-aged Adults: Evidence Summary
References (3)
Written by
ReCellence™ Editorial Team
Health Content Specialists
Medically reviewed by
Medical Review Board
MD, PhD
Last updated: March 8, 2026
Last medical review: March 8, 2026